Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 16, 2005
Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapyEva Poveda, Berta Rodés, Sophie Lebel-Binay, et al.
AIDS Research and Human Retroviruses|February 26, 2009
Raltegravir and etravirine are active against HIV type 1 group OVerónica Briz, Carolina Garrido, Eva Poveda, et al.
AIDS (London, England)|November 5, 2008
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analoguesEva Poveda, Carmen de Mendoza, Theresa Pattery, et al.
AIDS (London, England)|December 10, 2009
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitorEduardo Seclén, María Del Mar González, Angélica Corral, et al.
AIDS (London, England)|June 27, 2008
Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 yearsVerónica Briz, Eva Poveda, Mariola López, et al.
Antiviral Research|June 10, 2014
Update on hepatitis C virus resistance to direct-acting antiviral agentsEva Poveda, David L Wyles, Alvaro Mena, et al.
AIDS Research and Human Retroviruses|February 14, 2012
Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?Luz Martín-Carbonero, Norma I Rallón, José M Benito, et al.
Antiviral Therapy|March 23, 2012
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitorZulema Plaza, Vincent Soriano, Eugenia Vispo, et al.
AIDS (London, England)|November 16, 2010
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analoguesLuz Martín-Carbonero, Tiago Teixeira, Eva Poveda, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2007
Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 yearsVerónica Briz, Eva Poveda, María del Mar González, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 16, 2005
Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapyEva Poveda, Berta Rodés, Sophie Lebel-Binay, et al.
AIDS Research and Human Retroviruses|February 26, 2009
Raltegravir and etravirine are active against HIV type 1 group OVerónica Briz, Carolina Garrido, Eva Poveda, et al.
AIDS (London, England)|November 5, 2008
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analoguesEva Poveda, Carmen de Mendoza, Theresa Pattery, et al.
AIDS (London, England)|December 10, 2009
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitorEduardo Seclén, María Del Mar González, Angélica Corral, et al.
AIDS (London, England)|June 27, 2008
Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 yearsVerónica Briz, Eva Poveda, Mariola López, et al.
Antiviral Research|June 10, 2014
Update on hepatitis C virus resistance to direct-acting antiviral agentsEva Poveda, David L Wyles, Alvaro Mena, et al.
AIDS Research and Human Retroviruses|February 14, 2012
Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?Luz Martín-Carbonero, Norma I Rallón, José M Benito, et al.
Antiviral Therapy|March 23, 2012
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitorZulema Plaza, Vincent Soriano, Eugenia Vispo, et al.
AIDS (London, England)|November 16, 2010
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analoguesLuz Martín-Carbonero, Tiago Teixeira, Eva Poveda, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2007
Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 yearsVerónica Briz, Eva Poveda, María del Mar González, et al.
Pageof 15